Since, over half of the prostate cancer patients harbor TMPRSS2-ERG fusions, understanding the mechanistic role of ERG in mediating oncogenic transformation of prostate epithelium would facilitate better therapeutic strategies. The gene discussed is ERG; the disease is Familial prostate cancer.